copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Evolving Trends in Catheter-Directed Therapy for Venous Thrombosis: A . . . The authors write this letter to draw attention to the changing trends of utilization of catheter-directed thrombolytic therapy (CDT) for the treatment of venous thrombosis in the Medicare population from 2013 to 2022 These trends have been reported previously by Von Ende et al (1) from 2007 to 2017, utilizing the Centers for Medicare Medicaid Services (CMS) 5% research identifiable files
Catheter-Directed Therapies for Deep Vein Thrombosis and Pulmonary . . . Background Nationwide trends in the utilization of catheter-directed therapies for deep vein thrombosis and pulmonary embolism in the Medicare population are essential as they represent a major health care challenge The annual incidence and mortality with venous thromboembolism are around 900,000 and 60,000 to 100,000 patients, respectively, in the United States Methods Data were acquired
Trends in Advanced Treatment Utilization After Adoption of Large-bore . . . We assessed changes in trends in utilization of advanced treatments (systemic thrombolysis, catheter-directed thrombolysis, and large-bore embolectomy) and hospital practices following the adoption of large-bore embolectomy for patients with intermediate- and high-risk pulmonary embolism
Nationwide Trends in Use of Catheter-Directed Therapy for Treatment of . . . Methods Using a 5% national sample of Medicare claims data from 2004 to 2016, all claims associated with PE were identified The annual volume of 2 billable CDT services—arterial mechanical thrombectomy and transcatheter arterial infusion for thrombolysis—were determined to evaluate changes in CDT use and primary CDT operator specialty over
Utilization trends and outcomes of catheter-directed thrombolysis for . . . Contemporary data on catheter-directed thrombolysis (CDT) utilization trends and associated hospital outcomes in pulmonary embolism (PE) n the US is limited Using the nationwide inpatient sample database, we identified patients hospitalized for acute PE treated with CDT from January 1, 2008, to December 31, 2018 Cochrane-Armitage test was used to evaluate the temporal trends in utilization
Catheter directed thrombolysis for deep vein thrombosis in 2022 . . . The utilization of Catheter directed thrombolysis (CDT) as a treatment modality for patients with proximal and caval deep vein thrombosis (DVT) has increased over time despite conflicting evidence (Fig 1) [1, 2]
Trends in Percutaneous Device Use for the Treatment of Venous . . . In the PHD cohort, specific reperfusion devices were identified in 14,105 patients (PE 9,098, iDVT 5,007) In conclusion, the use of mechanical thrombectomy for the treatment of VTE has increased over time, whereas the rates of catheter-directed thrombolysis therapy have remained stagnant or decreased
Comparative Outcomes of Catheter-Directed Thrombolysis Plus . . . Bashir and colleagues compare in-hospital outcomes in the treatment of acute proximal deep vein thrombosis using anticoagulation plus catheter-directed thrombolysis (CDT) vs anticoagulation alone They also evaluate the temporal trends in CDT utilization and outcomes in proximal DVT treatment
Nationwide Trends of Catheter-Directed Therapy Utilization for . . . The annual volume of two services – venous percutaneous transluminal thrombectomy (CPT code 37187) and venous infusion for thrombolysis (CPT code 37201 from 2007-2012 and CPT code 37212 from 2013-2017) – were examined for trends in DVT intervention Utilization rates as well as region and place of service were calculated